Abbott Labs Beats, Raises Guidance and Dividend – ValueWalk Premium

Abbott Labs Beats, Raises Guidance and Dividend

Abbott Laboratories (NYSE:ABT) released its earnings report for the three months ended September 30 this afternoon before the market opened on Wall Street. The company showed earnings of $0.55 on revenue of $5.369 billion. Shares in the health care company closed at $3.71 on Tuesday's market.

In the lead up to the release of the Abbot Laboratories (NYSE:ABT) earnings report analysts studying Abbott Laboratories . . .


This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.

Saved Articles

The top investors are reading ValuewalkPremium.

Click here to learn why